SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 96 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $41,000 | -66.4% | 3,697 | -94.4% | 0.00% | -100.0% |
| Q1 2020 | $122,000 | +577.8% | 66,327 | +1175.0% | 0.00% | – |
| Q4 2019 | $18,000 | -79.5% | 5,202 | -87.4% | 0.00% | -100.0% |
| Q3 2019 | $88,000 | -57.3% | 41,178 | -46.7% | 0.00% | -50.0% |
| Q2 2019 | $206,000 | +186.1% | 77,322 | +159.3% | 0.00% | +100.0% |
| Q4 2018 | $72,000 | -81.6% | 29,818 | -66.4% | 0.00% | -66.7% |
| Q3 2018 | $391,000 | +10.1% | 88,860 | +80.0% | 0.00% | 0.0% |
| Q2 2018 | $355,000 | +1513.6% | 49,353 | +348.6% | 0.00% | – |
| Q2 2017 | $22,000 | -35.3% | 11,001 | +27.3% | 0.00% | – |
| Q1 2017 | $34,000 | -19.0% | 8,645 | 0.0% | 0.00% | – |
| Q4 2016 | $42,000 | +10.5% | 8,645 | +21.2% | 0.00% | -100.0% |
| Q1 2016 | $38,000 | +245.5% | 7,135 | +468.5% | 0.00% | – |
| Q3 2015 | $11,000 | -21.4% | 1,255 | +53.6% | 0.00% | – |
| Q2 2015 | $14,000 | -88.7% | 817 | -92.4% | 0.00% | -100.0% |
| Q1 2015 | $124,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 2,186,520 | $38,526,000 | 10.61% |
| Cormorant Asset Management, LP | 1,945,334 | $34,277,000 | 4.56% |
| Aisling Capital LLC | 1,703,855 | $30,022,000 | 4.47% |
| Wildcat Capital Management, LLC | 736,012 | $12,968,000 | 4.44% |
| ACUTA CAPITAL PARTNERS, LLC | 212,402 | $3,743,000 | 2.31% |
| Healthcare Value Capital, LLC | 50,000 | $881,000 | 0.92% |
| EAM Investors, LLC | 249,028 | $4,388,000 | 0.51% |
| TFS CAPITAL LLC | 150,812 | $2,657,000 | 0.26% |
| GAGNON SECURITIES LLC | 11,001 | $194,000 | 0.08% |
| Granite Investment Partners, LLC | 43,861 | $772,000 | 0.07% |